Jakarta - In an effort to improve the quality of health services in Indonesia, the Ministry of Health (MOH) continues to optimize the implementation of the National Formulary (Fornas). As a list of selected drugs that are needed and must be available in health care facilities, Fornas is an important element in supporting the implementation of the National Health Insurance (JKN) program.
Director General of Pharmaceuticals and Medical Devices, L. Rizka Andalucia emphasized the importance of updating Fornas periodically to adjust to the development of science and technology. “Fornas is reviewed every two years at the most, but under certain conditions changes can be made if there are drugs that are urgently needed or there is new evidence that supports adjustments,” Rizka said at the Fornas Monitoring and Implementation Dissemination event in Jakarta, Friday (13/12).
This dissemination event aims to socialize changes to Fornas as well as provide an understanding to stakeholders regarding the importance of implementing Fornas in health services. By being guided by Fornas, health service facilities (fasyankes) are expected to provide more efficient and effective services, so that national targets in JKN implementation can be achieved.

Updating Fornas 2024
The process of updating the latest edition of Fornas in 2024 has started from March to October 2024, involving the Fornas Drug Selection Team, the National Drug and Phytopharmaca Selection Committee and various relevant stakeholders.
The current Fornas, which was established through Minister of Health Decree (KMK) No. HK.01.07/MENKES/2197/2023, includes 672 active substances in 1,132 dosage forms. After the review process in 2024, the Fornas list was expanded to 677 active substances in 1,143 dosage forms as stipulated through the Fornas addendum in KMK No. HK.01.07/MENKES/1818/2024 which will take effect from February 1, 2025.
Rizka emphasized that monitoring and evaluation of the implementation of Fornas is carried out regularly to ensure the availability of drugs that are not only clinically appropriate, but also affordable, to support the sustainability of the JKN program.
“Fornas is a tangible manifestation of our commitment to provide the best service to the community. With strong cooperation, we are confident that we can fulfill the needs of medicines needed by the community in an appropriate and efficient way,” Rizka added.
The CERDAS (SMART) Principle in Fornas Development
Deputy Minister of Health, Prof. Dante Saksono Harbuwono, also appreciated the steps in developing Fornas, especially the addition of drug preparations to support the down-referral program. “With this down-referral program, we can provide more complete, cost-effective patient treatment, and make it easier for patients to get treatment. In the future, Fornas must be developed based on the CERDAS principle,” said Prof. Dante.
He explained the six CERDAS principles that guide the development of Fornas:
- Cermat (Meticulous) of using Health Technology Assessment (HTA).
- Empati (Empathy) to conditions in the field.
- Rasional (Rational) in quality and cost control.
- Dinamis (Dynamic) in keeping up with technology.
- Aktif (Active) in supporting pharmaceutical independence.
- Selalu (Always) community-oriented.
According to Prof. Dante, the CERDAS principle reflects the shared responsibility of all stakeholders in ensuring the quality of health services, while maintaining cost-effectiveness in treatment,” he said.
Collaboration for Better Health
As a joint reference for the central government, local governments, BPJS Kesehatan, and health facilities, Fornas plays a strategic role in ensuring the availability of medicines needed by the community.
Through updating the Fornas based on the CERDAS principle, the Ministry of Health is optimistic that it can continue to improve the quality of health services in Indonesia, support the sustainability of the JKN program, and create better health services for the entire community.